Merck Operating Income 2012-2025 | MKKGY

Merck annual/quarterly operating income history and growth rate from 2012 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.

Merck operating income for the quarter ending September 30, 2025 was $1.427B, a 18.32% increase year-over-year.
Merck operating income for the twelve months ending September 30, 2025 was $4.374B, a 17% increase year-over-year.
Merck annual operating income for 2024 was $3.945B, a 0.98% increase from 2023.
Merck annual operating income for 2023 was $3.907B, a 17.11% decline from 2022.
Merck annual operating income for 2022 was $4.714B, a 4.64% decline from 2021.

Merck Annual Operating Income (Millions of US $)
2024	$3,945
2023	$3,907
2022	$4,714
2021	$4,943
2020	$3,410
2019	$2,374
2018	$2,038
2017	$2,854
2016	$2,747
2015	$2,045
2014	$2,342
2013	$2,893
2012	$1,984
2011	$1,555

Merck Quarterly Operating Income (Millions of US $)
2025-09-30	$1,427
2025-06-30	$1,011
2025-03-31	$1,061
2024-12-31	$874
2024-09-30	$1,206
2024-06-30	$854
2024-03-31	$1,011
2023-12-31	$667
2023-09-30	$1,071
2023-06-30	$1,058
2023-03-31	$1,111
2022-12-31	$904
2022-09-30	$1,244
2022-06-30	$1,249
2022-03-31	$1,316
2021-12-31	$1,186
2021-09-30	$1,236
2021-06-30	$1,264
2021-03-31	$1,257
2020-12-31	$716
2020-09-30	$1,363
2020-06-30	$541
2020-03-31	$790
2019-12-31	$572
2019-09-30	$678
2019-06-30	$695
2019-03-31	$429
2018-12-31	$361
2018-09-30	$571
2018-06-30	$469
2018-03-31	$638
2017-12-31	$301
2017-09-30	$1,058
2017-06-30	$691
2017-03-31	$805
2016-12-31	$433
2016-09-30	$754
2016-06-30	$622
2016-03-31	$937
2015-12-31	$329
2015-09-30	$644
2015-06-30	$554
2015-03-31	$573
2014-12-31	$112
2014-09-30	$569
2014-06-30	$504
2014-03-31	$644
2013-12-31	$539
2013-09-30	$830
2013-06-30	$870
2013-03-31	$643
2012-12-31	$3,646
2012-09-30	$601
2012-06-30	$79
2012-03-31	$3,274
2011-12-31	$3,311
2011-09-30	$3,585
2011-06-30	$151
2011-03-31	$3,505

Sector	Industry	Market Cap	Revenue
Medical	Medical - Drug Manufacturing	$19.496B	$22.569B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.

Stock Name	Country	Market Cap	PE Ratio
Chugai Pharmaceutical (CHGCY)	Japan	$85.303B	32.40
Zoetis (ZTS)	United States	$54.932B	19.66
Takeda Pharmaceutical (TAK)	Japan	$51.421B	10.49
Daiichi Sankyo, - (DSNKY)	Japan	$39.630B	19.74
BeOne Medicines - (ONC)	Switzerland	$37.087B	196.62
Sandoz Group AG (SDZNY)	Switzerland	$33.939B	0.00
United Therapeutics (UTHR)	United States	$20.018B	17.62
Shionogi (SGIOY)	Japan	$15.261B	14.02
Neurocrine Biosciences (NBIX)	United States	$13.200B	31.67
Summit Therapeutics (SMMT)	United States	$13.140B	0.00
IPSEN (IPSEY)	France	$13.109B	0.00
Ionis Pharmaceuticals (IONS)	United States	$12.363B	0.00
Madrigal Pharmaceuticals (MDGL)	United States	$11.394B	0.00
Orion OYJ (ORINY)	Finland	$10.204B	29.15
Eisai (ESAIY)		$8.236B	0.00
Ono Pharmaceutical (OPHLF)	Japan	$6.576B	20.00
Stevanato Group S.p.A (STVN)	Italy	$5.981B	33.47
Crinetics Pharmaceuticals (CRNX)	United States	$5.313B	0.00
Hikma Pharmaceuticals Plc (HKMPF)	United Kingdom	$4.613B	0.00
AMNEAL PHARMACEUTICALS, INC (AMRX)	United States	$4.216B	20.01
Indivior (INDV)	United States	$4.068B	16.60
Corcept Therapeutics (CORT)	United States	$3.653B	39.47
NewAmsterdam Pharma (NAMS)	Netherlands	$3.589B	0.00
Hypermarcas (HYPMY)	Brazil	$3.047B	20.91
Centessa Pharmaceuticals (CNTA)	United Kingdom	$2.984B	0.00
Catalyst Pharmaceuticals (CPRX)	United States	$2.790B	8.90
Ocular Therapeutix (OCUL)	United States	$2.401B	0.00
Dyne Therapeutics (DYN)	United States	$2.386B	0.00
Soleno Therapeutics (SLNO)	United States	$2.282B	0.00
Avadel Pharmaceuticals (AVDL)	Ireland	$2.098B	0.00
Aurinia Pharmaceuticals Inc (AUPH)	Canada	$1.958B	23.20
Harrow (HROW)	United States	$1.774B	108.86
Guardian Pharmacy Services (GRDN)	United States	$1.712B	32.96
Ardelyx (ARDX)	United States	$1.640B	0.00
Oruka Therapeutics (ORKA)	United States	$1.617B	0.00
Enliven Therapeutics (ELVN)	United States	$1.585B	0.00
Amylyx Pharmaceuticals (AMLX)	United States	$1.570B	0.00
Collegium Pharmaceutical (COLL)	United States	$1.441B	7.14
BioCryst Pharmaceuticals (BCRX)	United States	$1.404B	83.25
Evotec AG (EVO)	Germany	$1.282B	0.00
Relay Therapeutics (RLAY)	United States	$1.274B	0.00
Xeris Biopharma Holdings (XERS)	United States	$1.248B	0.00
Savara (SVRA)	United States	$1.184B	0.00
ARS Pharmaceuticals (SPRY)	United States	$1.051B	0.00
Theravance Biopharma (TBPH)	United States	$1.014B	42.57
Cronos Group (CRON)	Canada	$0.967B	0.00
Xencor (XNCR)	United States	$0.913B	0.00
Nektar Therapeutics (NKTR)	United States	$0.766B	0.00
KalVista Pharmaceuticals (KALV)	United States	$0.738B	0.00
Ironwood Pharmaceuticals (IRWD)	United States	$0.732B	17.31
Esperion Therapeutics (ESPR)	United States	$0.727B	0.00
ProKidney (PROK)	United States	$0.689B	0.00
Rigel Pharmaceuticals (RIGL)	United States	$0.680B	6.07
Bioventus (BVS)	United States	$0.656B	13.44
Lexeo Therapeutics (LXEO)	United States	$0.539B	0.00
Elite Pharmaceuticals (ELTP)	United States	$0.506B	0.00
Lyell Immunopharma (LYEL)	United States	$0.505B	0.00
Zevra Therapeutics (ZVRA)	United States	$0.503B	0.00
Organogenesis (ORGO)	United States	$0.481B	0.00
Siga Technologies (SIGA)	United States	$0.471B	6.45
Altimmune (ALT)	United States	$0.442B	0.00
4D Molecular Therapeutics (FDMT)	United States	$0.431B	0.00
Nature's Sunshine Products (NATR)	United States	$0.421B	25.07
Aquestive Therapeutics (AQST)	United States	$0.404B	0.00
USANA Health Sciences (USNA)	United States	$0.401B	11.19
Akebia Therapeutics (AKBA)	United States	$0.361B	0.00
Achieve Life Sciences (ACHV)	Canada	$0.310B	0.00
Profound Medical (PROF)	Canada	$0.298B	0.00
Aclaris Therapeutics (ACRS)	United States	$0.284B	0.00
Avalo Therapeutics (AVTX)	United States	$0.279B	0.00
Aldeyra Therapeutics (ALDX)	United States	$0.279B	0.00
Relmada Therapeutics (RLMD)	United States	$0.274B	0.00
OmniAb (OABI)	United States	$0.274B	0.00
Heron Therapeutics (HRTX)	United States	$0.273B	0.00
Fractyl Health (GUTS)	United States	$0.262B	0.00
Larimar Therapeutics (LRMR)	United States	$0.259B	0.00
Protara Therapeutics (TARA)	United States	$0.259B	0.00
Silence Therapeutics (SLN)	United Kingdom	$0.238B	0.00
Enlivex Therapeutics (ENLV)	Israel	$0.223B	0.00
Journey Medical (DERM)	United States	$0.217B	0.00
Tonix Pharmaceuticals Holding (TNXP)	United States	$0.209B	0.00
Galectin Therapeutics (GALT)	United States	$0.196B	0.00
Minerva Neurosciences (NERV)	United States	$0.193B	0.00
Century Therapeutics (IPSC)	United States	$0.190B	0.00
Innate Pharma SA (IPHYF)	France	$0.181B	0.00
MediWound (MDWD)	Israel	$0.180B	0.00
Surrozen (SRZN)	United States	$0.171B	0.00
AleAnna (ANNA)	United States	$0.171B	0.00
VAXART, INC (VXRT)	United States	$0.169B	0.00
Procaps Group, S.A (PROCF)	Luxembourg	$0.161B	0.00
Corbus Pharmaceuticals Holdings (CRBP)	United States	$0.146B	0.00
Unicycive Therapeutics (UNCY)	United States	$0.133B	0.00
Context Therapeutics (CNTX)	United States	$0.132B	0.00
Incannex Healthcare (IXHL)	Australia	$0.131B	0.00
Inhibikase Therapeutics (IKT)	United States	$0.126B	0.00
Avita Medical (RCEL)	United States	$0.119B	0.00
Verrica Pharmaceuticals (VRCA)	United States	$0.116B	0.00
Karyopharm Therapeutics (KPTI)	United States	$0.116B	0.00
Prelude Therapeutics (PRLD)	United States	$0.114B	0.00
Pyxis Oncology (PYXS)	United States	$0.110B	0.00
Cardiol Therapeutics (CRDL)	Canada	$0.105B	0.00
Champions Oncology (CSBR)	United States	$0.100B	42.41
Cassava Sciences (SAVA)	United States	$0.099B	0.00
Vivani Medical (VANI)	United States	$0.093B	0.00
Korro Bio (KRRO)	United States	$0.083B	0.00
Assertio Holdings (ASRT)	United States	$0.074B	0.00
Gain Therapeutics (GANX)	United States	$0.070B	0.00
Cumberland Pharmaceuticals (CPIX)	United States	$0.070B	58.13
PolyPid (PYPD)	Israel	$0.069B	0.00
Dominari Holdings (DOMH)	United States	$0.069B	0.00
NRx Pharmaceuticals (NRXP)	United States	$0.067B	0.00
Arch Biopartners (ACHFF)	Canada	$0.066B	0.00
Rafael Holdings (RFL)	United States	$0.064B	0.00
Acrivon Therapeutics (ACRV)	United States	$0.062B	0.00
Metagenomi (MGX)	United States	$0.062B	0.00
Lipocine (LPCN)	United States	$0.062B	0.00
PMV Pharmaceuticals (PMVP)	United States	$0.060B	0.00
ElectroCore (ECOR)	United States	$0.057B	0.00
Nutriband (NTRB)	United States	$0.053B	0.00
Lite Strategy (LITS)	United States	$0.053B	0.00
Telomir Pharmaceuticals (TELO)	United States	$0.048B	0.00
Talphera (TLPH)	United States	$0.047B	0.00
Reviva Pharmaceuticals Holdings (RVPH)	United States	$0.041B	0.00
Plus Therapeutics (PSTV)	United States	$0.040B	0.00
FibroGen (FGEN)	United States	$0.039B	0.00
Kyntra Bio Inc (KYNB)	United States	$0.037B	0.00
Wellgistics Health (WGRX)	United States	$0.036B	0.00
Mural Oncology (MURA)	Ireland	$0.035B	0.00
MARKER THERAPEUTICS, INC (MRKR)	United States	$0.030B	0.00
Jupiter Neurosciences (JUNS)	United States	$0.030B	0.00
Natural Alternatives (NAII)	United States	$0.029B	0.00
SCYNEXIS (SCYX)	United States	$0.027B	0.00
TherapeuticsMD (TXMD)	United States	$0.026B	0.00
Klotho Neurosciences (KLTO)	United States	$0.024B	0.00
Scienture Holdings (SCNX)	United States	$0.022B	0.00
Liminatus Pharma (LIMN)	United States	$0.021B	0.00
Cosmos Health (COSM)	United States	$0.020B	0.00
Vivos Therapeutics (VVOS)	United States	$0.020B	0.00
Inotiv (NOTV)	United States	$0.020B	0.00
VYNE Therapeutics (VYNE)	United States	$0.019B	0.00
Iterum Therapeutics (ITRM)	Ireland	$0.018B	0.00
Citius Pharmaceuticals (CTXR)	United States	$0.018B	0.00
Traws Pharma (TRAW)	United States	$0.016B	0.02
Vyome Holdings (HIND)	United States	$0.016B	0.00
Mannatech (MTEX)	United States	$0.014B	0.00
Tempest Therapeutics (TPST)	United States	$0.013B	0.00
BioLineRx (BLRX)	Israel	$0.013B	0.00
Phio Pharmaceuticals (PHIO)	United States	$0.012B	0.00
CASI Pharmaceuticals (CASI)	China	$0.012B	0.00
China SXT Pharmaceuticals (SXTC)	China	$0.011B	0.00
Addex Therapeutics (ADXN)	Switzerland	$0.010B	0.00
Curanex Pharmaceuticals Inc (CURX)	United States	$0.010B	0.00
Mangoceuticals (MGRX)	United States	$0.010B	0.00
Ernexa Therapeutics (ERNA)	United States	$0.010B	0.00
Ainos (AIMD)	United States	$0.009B	0.00
BioVie (BIVI)	United States	$0.009B	0.00
Nuvilex (PMCB)	United States	$0.009B	0.00
XTL Biopharmaceuticals (XTLB)	Israel	$0.009B	0.00
Quoin Pharmaceuticals (QNRX)	United States	$0.009B	0.00
TransCode Therapeutics (RNAZ)	United States	$0.008B	0.00
Heatwurx (PCSA)	United States	$0.008B	0.00
Kiora Pharmaceuticals (KPRX)	United States	$0.008B	0.00
Biomerica (BMRA)	United States	$0.008B	0.00
Indaptus Therapeutics (INDP)	United States	$0.007B	0.00
Alaunos Therapeutics (TCRT)	United States	$0.007B	0.00
Redhill Biopharma (RDHL)	Israel	$0.007B	0.00
Aptorum Group (APM)	United Kingdom	$0.007B	0.00
Decoy Therapeutics Inc (DCOY)	United States	$0.006B	0.00
Sonoma Pharmaceuticals (SNOA)	United States	$0.006B	0.00
Xenetic Biosciences (XBIO)	United States	$0.006B	0.00
Jaguar Animal Health (JAGX)	United States	$0.005B	0.00
Salarius Pharmaceuticals (SLRX)	United States	$0.005B	0.00
XORTX Therapeutics (XRTX)	Canada	$0.004B	0.00
Clearmind Medicine (CMND)	Canada	$0.004B	0.00
Lyra Therapeutics (LYRA)	United States	$0.004B	0.00
InMed Pharmaceuticals (INM)	Canada	$0.003B	0.00
Shuttle Pharmaceuticals Holdings (SHPH)	United States	$0.003B	0.00
60 Degrees Pharmaceuticals (SXTP)	United States	$0.003B	0.00
Universe Pharmaceuticals INC (UPC)	China	$0.003B	0.00
CDT Equity (CDT)	United States	$0.002B	0.00
PainReform (PRFX)	Israel	$0.002B	0.00
Galmed Pharmaceuticals (GLMD)	Israel	$0.001B	0.00
Aditxt (ADTX)	United States	$0.001B	0.00
SciSparc (SPRC)	Israel	$0.001B	0.00
Emisphere Technologies (EMIS)	United States	$0.000B	0.00
Grifols, S.A (GRFS)	Spain	$0.000B	0.00
4D Pharma (LBPS)	United Kingdom	$0.000B	0.00
Patheon (PTHN)	Netherlands	$0.000B	0.00
RVL Pharmaceuticals (RVLP)	United States	$0.000B	0.00